Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs ServiceNow Inc (NOW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs ServiceNow Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while ServiceNow Inc trades at $138.81 (market cap $143.30B). The key difference: ServiceNow Inc is far larger — about 147.3× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and ServiceNow Inc is more actively traded (13,207,010 versus 4,325,710). Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and ServiceNow Inc for 54 Days on average.
| MRVI | NOW | |
|---|---|---|
Market Cap | $972.90M | $143.30B |
Volume | 4,325,710 | 13,207,010 |
Sector | Health | Technology |
52-Week High | $9.00 | $189.26 |
52-Week Low | $2.83 | $83.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $1.08B | $147.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
ServiceNow (NOW) trades at $140.32, down 0.38% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $0.90, and its AI business surpassed $1 billion in annual contract value. Revenue grew to $13.28 billion in 2025, with a net income margin of 11.34%, though valuation multiples remain elevated with a P/E of 86.63.
The outlook is positive, supported by robust AI adoption and enterprise demand, but risks include high valuation, competitive pressures, and potential margin compression. Analysts are overwhelmingly bullish with an 86.96% buy rating and a consensus price target of $150.71, suggesting upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About ServiceNow Inc
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management (ITSM), expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service (PaaS).
Read more on NOW →
